# Alavita Pharmaceuticals Inc — Form D

Alavita Pharmaceuticals Inc of MOUNTAIN VIEW, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-22. The offering totals $600K, of which $600K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-09-22
- Form: D
- Accession: 0001340978-09-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $600K
- Amount sold: $600K
- Investors: 36
- Date of first sale: 2009-09-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-81983

## Issuer

- Name: Alavita Pharmaceuticals Inc
- CIK: 0001340978
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 325 E. Middlefield Road, MOUNTAIN VIEW, CA, 94043
- Phone: 6509692405

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Sam Colella | Director | South San Francisco, CA |
| Richard Lerner | Director | Baltimore, MD |
| Gordon Ringold | Director | Truckee, CA |
| Isaac Stein | Director | Mountain View, CA |
| Alex Zaffaroni | Director | Mountain View, CA |
| Gordon Ringold | Executive Officer | Truckee, CA |

## More

- [CIK 1340978 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1340978&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001340978-09-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.